Growth charts for patients with Sanfilippo syndrome (Mucopolysaccharidosis type III)
Abstract Background Mucopolysaccharidosis (MPS) type III (Sanfilippo syndrome) comprises a group of rare, lysosomal storage diseases caused by the deficiency of one of four enzymes involved in the degradation of heparan sulfate. The clinical hallmark of the disease is severe neurological deteriorati...
Main Authors: | Nicole M. Muschol, Daniel Pape, Kai Kossow, Kurt Ullrich, Laila Arash-Kaps, Julia B. Hennermann, Ralf Stücker, Sandra R. Breyer |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-019-1065-x |
Similar Items
-
Hip pathologies in mucopolysaccharidosis type III
by: Sandra Rafaela Breyer, et al.
Published: (2021-03-01) -
Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease
by: Rachel Heon-Roberts, et al.
Published: (2020-01-01) -
Epidemiology of Sanfilippo syndrome: results of a systematic literature review
by: Tamás Zelei, et al.
Published: (2018-04-01) -
Mortality in patients with Sanfilippo syndrome
by: Christine Lavery, et al.
Published: (2017-10-01) -
In silico Analysis of Candidate Genes Involved in Sanfilippo Syndrome
by: Mehreen Zaka, et al.
Published: (2015-04-01)